1 of 2
Story summary
- Fenway Health, a key LGBTQ+ health center in Boston, has halted gender-affirming hormone therapy for patients under 19, effective immediately.
- Advocates view the move as capitulation to anti-trans policies by the Trump administration.
- Critics say the decision undermines Fenway Health's mission and endangers transgender youth.
- Fenway Health will assist affected patients in finding alternative care.
- Many families feel betrayed and fear ongoing access to necessary medical services.
1 / 2
